Thyroid clinic marketing: Hashimoto’s claims, lab range wording, animal-derived thyroid and supplement ads

A thyroid clinic is found by people who are tired of being tired. A woman in her forties with fatigue, weight gain and a family history of thyroid disease wants someone to look at her results. A man whose blood test came back “normal” still feels unwell and wants a second opinion. A patient newly told they have Hashimoto’s disease wants to know what it means for the rest of their life. The clinic may be an endocrinology practice with a thyroid focus, a primary care or functional medicine practice that markets thyroid care, or a telehealth service that orders labs and writes prescriptions. Thyroid ads and pages can carry promises about hidden thyroid problems, optimal ranges, reversing Hashimoto’s and natural thyroid, and a clinic that copies them takes on claims the federal sources do not support. This guide covers what NIDDK, MedlinePlus and FDA say, symptom quizzes, lab range wording, Hashimoto’s claims, supplements and iodine, animal-derived and compounded thyroid medicines, weight loss and adrenal fatigue claims, and the urgent wording a thyroid page needs.

Ten related topics have their own guides and are not repeated here. Thyroid condition pages, nodule and biopsy pages, radioiodine wording and endocrinology referrals in general are covered in our guide to endocrinology practice marketing. Root cause, functional testing and practice model claims are covered in our guide to functional medicine practice marketing, and integrative claims in our guide to integrative medicine marketing claims. Selling supplements is covered in our guide to selling supplements in a medical practice, compounded medicines in our guide to compounding pharmacy marketing, and lab tests sold straight to consumers in our guide to direct to consumer lab testing. Weight loss programs are covered in our guide to weight loss clinic marketing, hormone care in midlife in our guide to menopause clinic marketing, pregnancy care in our guide to OB-GYN practice marketing, and video visits and prescribing across state lines in our guide to telehealth marketing.

What NIDDK, MedlinePlus and FDA say

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) publishes the federal patient pages on thyroid disease, MedlinePlus from the National Library of Medicine explains thyroid tests and lab results, and the Food and Drug Administration (FDA) sets out its position on thyroid medicines and supplements. The points that shape a thyroid clinic’s marketing:

• The NIDDK Hypothyroidism page (last reviewed March 2021) lists symptoms such as fatigue, weight gain, trouble tolerating cold, joint and muscle pain, dry skin or thinning hair and depression, then says these symptoms, especially fatigue and weight gain, are widespread and do not necessarily mean a person has a thyroid problem. It says a hypothyroidism diagnosis cannot be based on symptoms alone, because its symptoms are the same as those of other diseases.
• The same page describes a blood test about 6 to 8 weeks after starting the medicine, another test after each dose change, and then a test in 6 months and once a year.
• The NIDDK Hashimoto’s Disease page (last reviewed June 2021) calls it an autoimmune disorder that can cause hypothyroidism and the leading cause of hypothyroidism, says hypothyroidism can be well controlled with thyroid hormone medicine taken as instructed with regular follow-up blood tests, says people with it can have no symptoms at first, and says treatment generally depends on whether the thyroid is damaged enough to cause hypothyroidism. If it is not, the doctor may simply check symptoms and thyroid hormone levels regularly. It says the disease is 4 to 10 times more likely in women than in men and more likely to develop in women ages 30 to 50.
• Both NIDDK pages say people with Hashimoto’s disease or other autoimmune thyroid disorders may be sensitive to harmful side effects from iodine, that foods with large amounts of iodine such as kelp and other seaweed may cause or worsen hypothyroidism, and that iodine supplements can have the same effect. The Hashimoto’s page says researchers are looking at how diet and supplements, including vitamin D and selenium, may affect the disease, but no specific guidance is currently available.
• The MedlinePlus page How to Understand Your Lab Results (last updated September 4, 2025) says reference ranges are based on results from large groups of healthy people, that the term “normal” can be misleading, that healthy people can have results outside the range, that a result inside the range does not ensure good health, and that labs can use different testing methods and different reference ranges.
• The FDA page FDA’s Actions to Address Unapproved Thyroid Medications (content current as of August 6, 2026) says animal-derived thyroid medications, also called desiccated thyroid extract, are not FDA approved, that tablets from the same batches may not provide the same thyroid hormone levels, that these products are not eligible for compounding, and that FDA recommends patients taking them talk to their doctor.
• Current prescribing information for a synthetic thyroid hormone tablet on DailyMed (published October 16, 2026) carries a boxed warning that thyroid hormones should not be used for the treatment of obesity or for weight loss, and that larger doses may produce serious or even life threatening toxicity.

Two points shape the marketing. First, the symptoms that bring people to a thyroid clinic, above all fatigue and weight gain, are the ones NIDDK says do not by themselves point to the thyroid, so a page that turns symptoms into a diagnosis says more than the sources do. Second, the federal sources describe hypothyroidism as a condition that is managed with medicine and regular blood tests, so the clinic’s real offer is careful testing, a clear explanation of results and follow-up over years.

Symptom quizzes and “hidden thyroid” claims

A symptom checklist is a reasonable way to help a reader decide whether to book. The trouble starts when the checklist gives an answer. NIDDK says a hypothyroidism diagnosis cannot be based on symptoms alone and that fatigue and weight gain do not necessarily mean a thyroid problem. A quiz that ends with “Your answers suggest an underactive thyroid” makes a diagnosis the agency says symptoms cannot make. A quiz that ends with “These symptoms have a number of causes, and a clinician can help find out which one applies to you” stays inside the source.

The same goes for claims that a large number of people have thyroid disease that their doctor missed. NIDDK says nearly 5 out of 100 Americans ages 12 and older have hypothyroidism, and that a majority of cases are mild or have few obvious symptoms. If a page quotes that figure, it should quote it as written, with the source and date, and not stretch it into a claim about the reader.

Phrases that need rewriting:

• “Tired, gaining weight, cold all the time? It’s your thyroid.” NIDDK says these symptoms do not necessarily mean a thyroid problem. Say they can have several causes and that testing helps find out.
• “Take our quiz to find out if you have hypothyroidism.” A diagnosis from symptoms. Call it a checklist to bring to a visit, and say only a clinician can diagnose.
• “Millions have a hidden thyroid problem their doctor missed.” An unsourced figure and a claim about other clinicians. Quote the NIDDK figure as written or remove it.
• “The thyroid doctor who finally listens.” Implies other clinicians do not. Describe how long visits last and what the clinician reviews.

Lab test wording: reference ranges, not “optimal” promises

Thyroid clinics market their testing, and the claims that sell it are about ranges. The MedlinePlus lab results page says a reference range is built from results of large groups of healthy people, that the term “normal” can be misleading, that labs can use different reference ranges, and that a person with a health problem can have results inside the range. A clinic can use that page to explain why it looks at the whole picture and may order more tests. It cannot turn it into a claim that standard ranges are wrong and its own range is right.

The MedlinePlus TSH test page (last updated October 30, 2024) says that if TSH results are not normal, the provider will probably order other thyroid blood tests, such as T4, T3 and thyroid antibody tests, and that people who take thyroid hormone medicine have regular TSH tests to check the dose. The NIDDK Thyroid Tests page, last reviewed May 2017, says health care professionals generally check TSH first. That page is older, so check newer NIDDK and MedlinePlus pages before a test page relies on it, and say which source and date it follows. A test menu page can list the tests the clinic orders, say what each one measures in the words of those pages, and say the clinician decides which tests a patient needs.

Phrases that need rewriting:

• “We treat to optimal, not normal.” Implies the clinic’s own target range gives a better result. Describe how the clinician reads results with symptoms and history, and promise no range.
• “Your labs were normal but you still have hypothyroidism.” A diagnosis from the page. Say that a result inside the reference range does not rule out a health problem, in the MedlinePlus words, and that the clinician decides what further testing is needed.
• “The full thyroid panel your doctor won’t order.” A claim about other clinicians. List the tests and say what each measures.
• “Find the root cause with our complete thyroid panel.” A test does not find a cause on its own. Say what the test measures and that the clinician interprets it.

Hashimoto’s: “reverse”, “heal” and protocol claims

Hashimoto’s pages can carry claims such as reverse it, put it into remission, heal the gut to heal the thyroid. NIDDK describes it as an autoimmune disorder in which the immune system attacks the thyroid, says treatment generally depends on whether the thyroid is damaged enough to cause hypothyroidism, and says the treatment for that hypothyroidism is thyroid hormone medicine with regular follow-up blood tests. On diet, it says researchers are looking at vitamin D and selenium but no specific guidance is currently available, and it warns that large amounts of iodine may cause or worsen hypothyroidism. Both pages are from 2021, so check newer NIDDK and MedlinePlus pages before a Hashimoto’s page relies on them, and say which source and date it follows.

A Hashimoto’s page can explain the condition in NIDDK’s words, describe the tests used to diagnose it, explain that a person without hypothyroidism may be watched with regular checks, and describe what the clinic’s follow-up looks like. It should not offer a protocol that reverses the disease or lowers antibodies as a promised result.

Phrases that need rewriting:

• “Reverse Hashimoto’s naturally.” No source here supports reversal. Describe diagnosis, monitoring and treatment in NIDDK’s words.
• “Our autoimmune protocol lowers thyroid antibodies.” A health benefit claim that needs competent and reliable scientific evidence, as the FTC section below explains. Remove it unless counsel has reviewed the evidence.
• “Heal your gut, heal your thyroid.” No source here supports it. Remove it.
• “Go gluten-free to stop the autoimmune attack.” NIDDK says no specific diet guidance is currently available. If the clinic has a dietitian, describe the dietitian’s work instead.

Supplements, iodine and “thyroid support” products

Supplements are sold in and around thyroid clinics, and the iodine warning makes them a safety issue as well as an advertising one. NIDDK says people with Hashimoto’s disease or other autoimmune thyroid disorders may be sensitive to harmful side effects from iodine and that iodine supplements may cause or worsen hypothyroidism, and it tells readers to talk with their health care team about iodine supplements and about cough syrups that may contain iodine. The FDA Questions and Answers on Dietary Supplements (content current as of August 27, 2026) says supplements do not need FDA approval before they are marketed, and that a product intended to diagnose, treat, cure or prevent a disease is a drug and not a supplement.

A clinic that sells supplements can describe what the product is and why the clinician might suggest it for a particular patient, with the FDA and NIDDK lines in view. A “thyroid support” blend that promises to fix low thyroid function is a disease claim, and one that contains iodine or seaweed sits against the NIDDK warning for people with Hashimoto’s disease.

Phrases that need rewriting:

• “Natural thyroid support that restores healthy thyroid function.” A disease claim for a supplement. Remove it.
• “Iodine to boost your thyroid.” NIDDK says iodine supplements may cause or worsen hypothyroidism in people with autoimmune thyroid disorders. Remove it, and add the NIDDK line about talking with the care team.
• “Selenium and vitamin D protocol for Hashimoto’s.” NIDDK says no specific guidance is currently available. Do not sell it as treatment.
• “Glandular support from real thyroid tissue.” Implies a thyroid hormone effect from a product sold outside the prescription system. Remove it and have counsel review the product.

Under 15 U.S.C. 45, deceptive acts or practices in commerce are unlawful, and 15 U.S.C. 52 prohibits false advertisements likely to induce the purchase of drugs, devices, services or cosmetics. The FTC staff Health Products Compliance Guidance says claims about the health benefits or safety of health-related products require competent and reliable scientific evidence, and that an advertiser is responsible for the claims its ads convey, including implied ones. “Feel like yourself again” next to a thyroid supplement is a health benefit claim even if no condition is named.

Animal-derived and compounded thyroid medicines

“Natural thyroid” appears in thyroid clinic ads, and FDA has now set out its position in detail. Its August 2026 page says animal-derived thyroid medications are made from dried, ground animal thyroid glands, are not FDA approved, and contain compounds that are uncharacterized for safety and effectiveness. It says tablets from the same batches may not provide the same thyroid hormone levels, that inconsistent doses can have serious consequences, that FDA has received complaints and adverse event reports, and that FDA estimates 1.5 million patients received prescriptions for these medications from U.S. outpatient retail and mail-order pharmacies in 2024. It says FDA plans guidance on its compliance priorities, applies a risk-based enforcement approach, and recommends that patients taking these medications talk to their doctor. It also says these products are not eligible for compounding, because they are regulated as biological products under the Public Health Service Act. The earlier FDA consumer update Older Therapies Aren’t Necessarily Better for Thyroid Hormone Replacement (content current as of January 4, 2023) makes the same point about inconsistent doses.

Prescribing is the clinician’s decision, and this guide does not tell a clinic what to prescribe. The marketing question is narrower: a page or ad that presents an unapproved medicine as the better or more natural choice, or that offers it compounded, runs against what FDA says. Name no products, brands or doses in ads or on pages. If the clinic prescribes thyroid medicine, say the clinician reviews treatment options with each patient, and link the FDA page so readers can check where it stands. Have counsel review any page that mentions animal-derived or compounded thyroid medicine before it goes live, and recheck the FDA page when its guidance is published.

Phrases that need rewriting:

• “Natural desiccated thyroid, the way nature intended.” Presents an unapproved medicine as the better choice. Remove it, and name no product.
• “Custom compounded thyroid made just for you.” FDA says animal-derived thyroid medications are not eligible for compounding. Remove it and have counsel review any compounded thyroid offer.
• “Finally get off synthetic hormones.” Steers readers away from FDA-approved treatment their clinician may recommend. Remove it.
• “We prescribe what your doctor won’t.” A claim about other clinicians and an offer to prescribe before an evaluation. Describe the evaluation instead.

Weight loss and “adrenal fatigue” claims

Weight comes up on thyroid pages because NIDDK lists weight gain as a symptom, and it is where a thyroid offer can turn into something the label warns against. Current prescribing information for a synthetic thyroid hormone tablet carries a boxed warning that thyroid hormones should not be used for the treatment of obesity or for weight loss, that doses within the range of daily hormone requirements are ineffective for weight reduction in people with normal thyroid function, and that larger doses may produce serious or even life threatening toxicity. A page that ties thyroid treatment to weight loss, or offers thyroid medicine as part of a weight program, sits against that warning. If the clinic runs a weight program, our weight loss clinic guide covers the claims.

“Adrenal fatigue” can appear next to thyroid offers. NIDDK describes adrenal insufficiency, a disorder in which the adrenal glands do not make enough of certain hormones, and its Diagnosis page (last reviewed September 2018) says doctors diagnose it with blood tests. A 2016 systematic review in BMC Endocrine Disorders, available on the National Library of Medicine’s PubMed Central, concluded that there is no substantiation that “adrenal fatigue” is an actual medical condition. A clinic that markets diagnosis or treatment of adrenal fatigue is making a health claim with no support in those sources.

Phrases that need rewriting:

• “Fix your thyroid, lose the weight.” Ties treatment to weight loss against the boxed warning. Remove it.
• “Thyroid boost for stubborn weight.” The same problem. Remove it, and send readers to the weight program page if there is one.
• “Adrenal fatigue testing and recovery program.” No support in the sources above. Remove it, and describe what the clinic does test for.
• “Burnout is your adrenals and thyroid.” A diagnosis from a symptom. Say fatigue has several causes and a clinician can help find out which.

Urgent wording on every page and in every tool

Two emergencies sit at the edges of thyroid care. NIDDK says severe untreated hypothyroidism may, in rare cases, lead to myxedema coma, an extreme form in which the body’s functions slow to a life-threatening point, and that it requires immediate medical treatment. The MedlinePlus encyclopedia page Thyroid storm (review date January 25, 2026) calls thyroid storm a medical emergency, lists symptoms including agitation, a change in alertness, confusion, a pounding heart, increased temperature and sweating, and tells people with hyperthyroidism who have those symptoms to call 911 or the local emergency number. Put a short version on the thyroid pages, above the booking button: if you have an overactive thyroid and develop confusion, agitation, a pounding heart, a high temperature or a change in alertness, call 911. Then add the general line, “If you think you are having a medical emergency, call 911”, and the clinic’s line at [phone] with who answers it and when.

NIDDK also says a woman taking thyroid hormone medicine may need a higher dose during pregnancy and should contact her doctor right away on finding out she is pregnant. A pregnancy line belongs on the medication and follow-up pages, with the clinic’s number. The same urgent and pregnancy wording belongs on voicemail, after-hours messages, patient portal autoreplies, text replies, chat widgets and AI front desk tools. A message that says “my heart is racing and I feel confused” is not a scheduling request. The tool should give the urgent wording and the 911 line at once and alert staff, not judge the symptom or offer the next open slot. Our guides to AI chatbots on practice websites and answering services and AI receptionists cover how those tools hand off urgent messages.

Phrases that need rewriting:

• “Thyroid symptoms? Book online.” Put the urgent wording and the 911 line first, and the booking form after them.
• “Message your thyroid team anytime.” Say who reads messages, during which hours, that the inbox is not watched around the clock, and give the 911 line.
• “Pregnant? Keep taking your current dose.” Dose changes are the clinician’s decision, and NIDDK says to contact the doctor right away. Give the clinic’s number instead.

Prices and free offers

Thyroid clinics advertise lab panels, memberships and visit packages. Our guides to advertising cash prices and good faith estimates for self-pay patients cover how to state a price and what uninsured and self-pay patients must receive. A “free thyroid panel” or “free thyroid consultation” follows 16 CFR 251.1, which says a free offer must not be recouped through a raised price or a reduced quantity or quality elsewhere, and the terms of the offer should be stated at the outset. A free test that leads only to a paid supplement plan needs counsel’s review.

Referrals, labs, pharmacies and supplement makers

Thyroid care draws partners: primary care offices, OB-GYN practices, reference labs, compounding and mail-order pharmacies, supplement makers with practitioner programs and telehealth platforms. Under 42 U.S.C. 1320a-7b(b), the federal anti-kickback statute, it is a crime to knowingly and willfully offer, pay, solicit or receive any remuneration to induce or reward referrals of items or services payable by a federal health care program. Where a clinic bills Medicare or Medicaid, the statute can reach each partnership on this list. Rules on referral fees are also set state by state. Our guide to patient and physician referrals covers the general rules.

For a thyroid clinic, keep these points:

• Do not give gifts, meals, free services or payments to referral sources in return for patients without counsel’s review.
• Lab, pharmacy and supplement maker agreements, including revenue shares, markups and practitioner discounts, go to counsel before any agreement is signed. Payments to physicians from drug and device makers may be reported publicly; our guide to Open Payments covers that.
• Patients choose where to fill prescriptions and buy supplements. Do not make care conditional on using the clinic’s partner pharmacy or store.
• Patients are not paid or given gifts for choosing the clinic or for referring others.
• Practices that see Medicaid patients follow the rules in our guide to marketing to Medicaid patients.

Privacy, pixels and ads

A visit to a Hashimoto’s page, a booking for a thyroid consultation or an order for a thyroid panel says something about a person’s health. Keep bookings, intake answers, lab orders, results and page clicks out of tracking pixels and ad platform tools unless a written agreement covers them; our guide to tracking pixels on practice websites covers the setup. The Google Ads personalized advertising policy lists health among its sensitive interest categories and restricts targeting based on it. Ads can target by place and by search terms, and should not be built from a list of patients with thyroid disease.

Under 45 CFR 164.501, a reminder about the practice’s own treatment for an individual, such as a follow-up blood test that is due, can fall outside the definition of marketing, while a message that promotes a third party’s product, such as a supplement maker’s line, generally needs a signed authorization under 45 CFR 164.508. A supplement promotion sent to patients with a thyroid diagnosis needs counsel’s review before it goes out.

Patient stories

A patient who describes finally understanding their results, or how follow-up visits work, can help a reader who feels unheard. It is still one person’s experience. Under 16 CFR 255.2, an ad that shows one person’s result on a key attribute is likely to be read as what others will generally achieve, unless the advertiser has substantiation for that or clearly and conspicuously discloses what people can generally expect. “I lost the weight and my energy came back” is a results claim, and the weight part sits against the boxed warning above. Keep stories to the experience of care, name no medicine or supplement, and pair them with the NIDDK wording that symptoms vary and do not by themselves show a thyroid problem.

Get a signed authorization under 45 CFR 164.508 where the practice is a covered entity, and consent for any photo or video. Say if the patient received anything for taking part, and let the patient review the final version. Our guide to testimonials and before and after photos covers the full rules.

Illustration: two thyroid clinic pages

Illustration: a page reads “Tired, gaining weight, cold all the time? It’s your thyroid, even if your labs are normal. We treat to optimal, not normal, with natural desiccated thyroid and our Hashimoto’s reversal protocol. Add our iodine thyroid support and lose the weight for good. Book online.” It diagnoses from symptoms, claims a better range, promotes an unapproved medicine as the natural choice, promises to reverse an autoimmune disease, sells iodine to people NIDDK warns about, ties treatment to weight loss against the boxed warning, and has no urgent wording.

Illustration: a second page for the same practice reads “If you have an overactive thyroid and develop confusion, agitation, a pounding heart, a high temperature or a change in alertness, call 911. Fatigue and weight gain have several causes. At [Practice name], [Clinician name, license] reviews your history and symptoms, orders the tests you need and explains what each result means, including what a reference range can and cannot tell you. If you are pregnant and take thyroid medicine, call us at [phone]. Clinic hours are [days and hours].” It puts the urgent wording first, uses the agency’s words on symptoms and ranges, and promises nothing it cannot show.

Checklist before a thyroid campaign goes live

• NIDDK, MedlinePlus and FDA pages named and dated, with a “last reviewed” date and reviewer on condition and test pages; the 2017 and 2021 NIDDK pages checked against newer NIDDK and MedlinePlus pages.
• Symptom checklists end with “a clinician can help find out”, not a diagnosis.
• No “optimal range” or “normal labs but still sick” claims; range wording follows the MedlinePlus lab results page.
• No promise to reverse or heal Hashimoto’s or to lower antibodies.
• No iodine or seaweed product promoted to people with autoimmune thyroid disease; supplement copy follows the FDA Q&A and the NIDDK iodine warning.
• No animal-derived or compounded thyroid medicine promoted as better or natural; no product names, brands or doses; counsel has reviewed any page that mentions them.
• No thyroid treatment tied to weight loss; no adrenal fatigue testing or treatment offers.
• Thyroid storm and 911 wording above any booking button, the pregnancy line on medication pages, and the same in voicemail, portal replies, text replies, chat and AI front desk tools.
• Free offers follow 16 CFR 251.1; cash prices and good faith estimates follow their guides.
• Lab, pharmacy and supplement maker agreements reviewed by counsel; no care conditional on a partner pharmacy or store.
• Bookings, lab orders and results stay out of pixels and ad audiences; targeting by place and search terms only.
• Stories have signed authorizations, name no medicine or supplement, make no weight or results claim and carry a statement of what people can generally expect.

How we help

We build websites, local search, Google Ads and AI front desk tools for independent practices and health businesses, including endocrinology, primary care and functional medicine practices that offer thyroid care. For a thyroid clinic, that means a site that explains symptoms, tests and reference ranges in the words of NIDDK and MedlinePlus, puts the urgent wording above the booking button, and keeps supplement, compounded medicine and weight claims off the page, plus booking and lab request forms that keep diagnoses and results off the web and away from tracking tools. Our front desk tools hand urgent messages to the urgent wording, the clinic’s line and the 911 line, and do not triage symptoms. We do not decide who needs treatment or what to prescribe; your clinicians do. Our tools are built with HIPAA in mind. We confirm in writing what a BAA covers before any patient information flows through a tool, and if it is not covered, we do not route patient information through it. We are not a healthcare provider and we do not give legal or medical advice. We do not sell lead lists and we do not pay for referrals. For the wider rules, see our healthcare marketing rules hub.

Sources

• NIDDK: Hypothyroidism (Underactive Thyroid) (last reviewed March 2021)
• NIDDK: Hashimoto’s Disease (last reviewed June 2021)
• NIDDK: Thyroid Tests (last reviewed May 2017)
• NIDDK: Diagnosis of Adrenal Insufficiency and Addison’s Disease (last reviewed September 2018)
• MedlinePlus: Hypothyroidism (last updated August 5, 2026)
• MedlinePlus: TSH (Thyroid-stimulating hormone) Test (last updated October 30, 2024)
• MedlinePlus: How to Understand Your Lab Results (last updated September 4, 2025)
• MedlinePlus Medical Encyclopedia: Thyroid storm (review date January 25, 2026)
• FDA: FDA’s Actions to Address Unapproved Thyroid Medications (content current as of August 6, 2026)
• FDA: Older Therapies Aren’t Necessarily Better for Thyroid Hormone Replacement (content current as of January 4, 2023)
• FDA: Questions and Answers on Dietary Supplements (content current as of August 27, 2026)
• DailyMed: prescribing information for a synthetic thyroid hormone tablet, boxed warning (published October 16, 2026)
• BMC Endocrine Disorders: Adrenal fatigue does not exist, a systematic review (2016), via PubMed Central
• 15 U.S.C. 45: Unfair methods of competition unlawful
• 15 U.S.C. 52: Dissemination of false advertisements
• FTC: Health Products Compliance Guidance (December 2022)
• 16 CFR 251.1: Guide concerning use of the word free and similar representations
• 42 U.S.C. 1320a-7b: Criminal penalties for acts involving Federal health care programs
• 45 CFR 164.501: Definitions
• 45 CFR 164.508: Uses and disclosures for which an authorization is required
• 16 CFR 255.2: Consumer endorsements
• Google Ads: Personalized advertising policy

More in Physician specialty marketing